neffy is commercially available in the U.S. for the emergency treatment of allergic reactions, including anaphylaxis, in ...
Glenmark Pharmaceuticals Inc., USA (Glenmark) announces the launch of Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial. Glenmark's Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) ...
Glenmark Pharmaceuticals said that its wholly owned subsidiary, Glenmark Pharmaceuticals Inc., USA, has announced the launch of Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial in ...
Expands Amneal’s injectables portfolio with an essential medicine used in hospitals for emergency and perioperative care BRIDGEWATER, N.J., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The development process for the ...
The MarketWatch News Department was not involved in the creation of this content. 34-member international panel led by experts at Cincinnati Children's offers first consensus guidelines that seek to ...
(RTTNews) - Amneal Pharmaceuticals, Inc. (AMRX) announced that the U.S. FDA has approved its Epinephrine injection USP, 1 mg/mL, in both single-dose and multi-dose for use in U.S. hospitals.